News

Exposure to lead may be linked to cognitive problems decades later, according to three studies presented at the Alzheimer’s ...
Patients who used combinations of cardiovascular therapies experienced slower cognitive decline and fewer neuropathologies ...
Julia A. Haller, MD, ophthalmologist-in-chief at Wills Eye Hospital, has been named CEO, succeeding Joseph P. Bilson, ...
There was a lot of excitement when Tepezza became the first drug approved for the treatment of thyroid eye disease in January ...
Lyme disease is a complex condition with a long history of misdiagnosis, and Lyme arthritis, a late manifestation of the ...
Nicotine ingestions among young children declined 2015, but nicotine pouch ingestions more than 700% 2020, according to a ...
Tirzepatide may confer larger increases in testosterone levels among men with metabolic hypogonadism than testosterone ...
Declining physical activity in the years leading up to a heart-related event was frequent, with even steeper declines ...
A multi-ancestry polygenic risk score could help health care professionals predict a person’s risk for developing obesity ...
A high dose of centanafadine was shown to be safe and effective at lowering ADHD symptoms for adolescents, according to ...
One drop of Miebo had no significant impact on presurgical corneal measurements taken within 60 minutes of instillation, ...
Commonly used sulfonylureas were associated with an up to 13% increase in risk for major adverse CV events vs.